About
Kenneth Frazier is chairman of the board and chief executive officer of Merck & Co., Inc. Previously, Ken served as president of Merck with responsibility for the company’s three major divisions: Global Human Health, Merck’s sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization. Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of Public Affairs in 1994, and, in 1997, assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and The Merck Company Found
Position in the VCSift Database
- • 16 investors at Merck are tracked.
- • 3 investors hold the CEO and Chairman of the Board role in VCSift. Kenneth Frazier is one of them.
- • 2 investors are based in Kenilworth, New Jersey, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Kenilworth, US
Contact Information
Find more investors like Kenneth
Search Investors